CAR-T Innovation: Balancing Allogeneic And Autologous Cell Therapy

The CAR-T therapy landscape presents both immense promise and unique challenges for manufacturers. This on-demand webinar delves into the critical pain points faced by the industry, offering strategic insights to navigate the complex development of both allogeneic and autologous treatments. Discover how to balance cutting-edge technological advancements with the urgent need for cost reduction and increased accessibility, all while streamlining regulatory pathways.

Hear from Thermo Fisher Scientific experts on how to strategize for balanced allogeneic and autologous development by 2030. Don't miss out on these crucial insights. Watch the presentation below.